Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
glimepiride atp-binding cassette transporter c8 NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.81 approved blocker
glimepiride atp-binding cassette sub-family c member 8 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.81 approved inducer
glimepiride atp-binding cassette transporter c8 NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.81 approved unknown
glimepiride atp-binding cassette sub-family c member 8 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 2.81 approved inducer,blocker
glimepiride atp-binding cassette transporter c9 NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 0.88 approved unknown
glimepiride atp-sensitive inward rectifier potassium channel 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.41 approved inhibitor
glimepiride atp-sensitive inward rectifier potassium channel 11 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.57 approved inhibitor,blocker
glimepiride atp-sensitive inward rectifier potassium channel 11 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Hyperglycemia[MeSHID:D006943]
Diet therapy[MeSHID:D004035]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Complications of Diabetes Mellitus[MeSHID:D048909]		 3.57 approved inhibitor
click here to return to the previous page